Martin H. Van Vliet
0000-0002-6096-5635
3 papers found
Refreshing results…
Prognostic and predictive performance of R-ISS with SKY92 in older patients with multiple myeloma: the HOVON-87/NMSG-18 trial
Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model
Gene networks constructed through simulated treatment learning can predict proteasome inhibitor benefit in Multiple Myeloma
Missing publications? Search for publications with a matching author name.